New smart drug hunts and kills Hard-to-Treat cancers
Disease control
Recruiting now
This early-phase study tests OBT076, a drug that acts like a guided missile: it targets a protein called CD205 found on cancer cells and delivers a powerful anti-cancer drug directly to them. The study enrolls about 200 adults with advanced solid tumors that have come back or spr…
Phase: PHASE1 • Sponsor: Oxford BioTherapeutics Ltd • Aim: Disease control
Last updated May 14, 2026 12:02 UTC